Stockreport

Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition [Yahoo! Finance]

Bio-Rad Laboratories, Inc. Class A  (BIO) 
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm Check Earnings Report
PDF The stock carries a Zacks Rank #4 (Sell) currently. Since the beginning of 2023, Bio-Rad has been witnessing softness in smaller BioPharma companies, where historicall [Read more]